Next Article in Journal
Effect of Bilastine on Diabetic Nephropathy in DBA2/J Mice
Next Article in Special Issue
Cell and Molecular Biology of Thyroid Disorders
Previous Article in Journal
Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft Rejection
Previous Article in Special Issue
Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 20
Issue 10
10.3390/ijms20102553
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Fighting Thyroid Cancer with Microgravity Research

by
Marcus Krüger
1,
Daniela Melnik
1,
Sascha Kopp
1,
Christoph Buken
1,2,
Jayashree Sahana
2,
Johann Bauer
3,
Markus Wehland
1,
Ruth Hemmersbach
4,
Thomas J. Corydon
2,5,
Manfred Infanger
1 and
Daniela Grimm
1,2,6,*
1
Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University, 39120 Magdeburg, Germany
2
Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark
3
Max Planck Institute of Biochemistry, 82152 Martinsried, Germany
4
Institute of Aerospace Medicine, Gravitational Biology, German Aerospace Center (DLR), Linder Höhe, 51147 Cologne, Germany
5
Department of Ophthalmology, Aarhus University Hospital, 8200 Aarhus N, Denmark
6
Gravitational Biology and Translational Regenerative Medicine, Faculty of Medicine and Mechanical Engineering, Otto von Guericke University, 39120 Magdeburg, Germany
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(10), 2553; https://doi.org/10.3390/ijms20102553
Submission received: 17 April 2019 / Revised: 17 May 2019 / Accepted: 23 May 2019 / Published: 24 May 2019
(This article belongs to the Special Issue Cell and Molecular Biology of Thyroid Disorders)
Browse Figures
Versions Notes

Abstract

:
Microgravity in space or simulated by special ground-based devices provides an unusual but unique environment to study and influence tumour cell processes. By investigating thyroid cancer cells in microgravity for nearly 20 years, researchers got insights into tumour biology that had not been possible under normal laboratory conditions: adherently growing cancer cells detach from their surface and form three-dimensional structures. The cells included in these multicellular spheroids (MCS) were not only altered but behave also differently to those grown in flat sheets in normal gravity, more closely mimicking the conditions in the human body. Therefore, MCS became an invaluable model for studying metastasis and developing new cancer treatment strategies via drug targeting. Microgravity intervenes deeply in processes such as apoptosis and in structural changes involving the cytoskeleton and the extracellular matrix, which influence cell growth. Most interestingly, follicular thyroid cancer cells grown under microgravity conditions were shifted towards a less-malignant phenotype. Results from microgravity research can be used to rethink conventional cancer research and may help to pinpoint the cellular changes that cause cancer. This in turn could lead to novel therapies that will enhance the quality of life for patients or potentially develop new preventive countermeasures.

Graphical Abstract

1. Introduction

For cancer biologists, microgravity-based research is still an unusual terrain. Microgravity (µg) provides a physical condition that is not possible on Earth and interestingly, this condition may be ripe for studying cancer [1,2]. The use of µg for cancer research was born at the end of the last millennium. During the STS-90 (Space Transportation System) mission in 1998, primary cultures of human renal cortical cells were cultured for six days aboard the space shuttle Columbia before they returned to Earth for analysis. Hammond et al. [3] reported an alteration of 1632 of the 10,000 analyzed genes relative to ground controls. This was the first experiment to show that reduced gravity can affect a wide range of genes of in vitro cultured cells. These findings led to the speculation that weightlessness could also trigger cancer cells to change the expression of numerous proteins, which could be the basis for the development of new targets for drugs.
Inside the human body, the cells normally grow surrounded by a structure-supporting extracellular matrix together with a regulating biochemical microenvironment, which allows organs, as well as tumours, to maintain their three-dimensional (3D) shapes. Under normal laboratory conditions, adherent cells in vitro do not behave similarly to how they would react in vivo in the body: They grow two-dimensionally (2D), spreading out into monolayers on Petri dishes or polystyrene surfaces, which poses problems for scientists who study cancer by examining genetic changes affecting cell growth and development [4]. During the last decades, scientists have developed several laboratory methods to mimic the 3D growth of cancer cells.
Scaffold-based, spinner flask, liquid-overlay and hanging drop techniques were used to gain multicellular spheroids (MCS). But from a certain size, these MCS showed necrosis inside [5]. Under µg conditions, cells can arrange themselves scaffold-free into large MCS without any signs of necrosis [6]. MCS can help to develop new cancer treatment strategies, which might be later translated into in vivo models. Today they represent a useful model for studying angiogenesis mechanisms and performing pharmacological testing of chemotherapeutic agents such as tyrosine kinase inhibitors (lenvatinib, sunitinib, sorafenib etc.), which are often used in metastatic cancer therapy [7]. In addition, they can be applied in toxicological and radiation experiments [8,9].
Thyroid cancer is the most common form of endocrine malignancy. Over the past four decades, incidence rates have increased worldwide [10]. According to the Global Cancer Statistics GLOBOCAN, 567,233 new cases were diagnosed in the world population, and 41,071 people died from thyroid cancer in 2018 [11]. Poorly differentiated thyroid tumours are aggressive and metastasize early, resulting in poor prognosis. Also, differentiated (papillary or follicular) thyroid cancer, that is usually well treatable, could—in its recurrent form—become less-differentiated by diminishing its iodine uptake capability. Thus, current treatment options for recurrent differentiated thyroid cancer are extremely limited and patients show remarkably reduced survival. Scientists have searched intensely for new ways/methods to identify targets for novel drugs—and some of them have considered to use experimentation in altered gravity conditions (Figure 1) [12,13].

2. Ground-Based Techniques Allow Microgravity Research on Earth

Experiments in real µg (parabolic flights, sounding rocket flights, experiments on satellites, space vehicles or space stations (Figure 2A)) are rare and expensive. For this reason, different ground-based facilities have been developed to simulate µg on Earth [1]. Devices such as the fast-rotating clinostat (FRC) [14], the rotating wall vessel (RWV) [15] or the random positioning machine (RPM) [16,17] allow cost-efficient preparations of spaceflights as well as intensive research in stand-alone studies (Figure 2B). The ground-based facilities have been shown to imitate µg effects for several (but for not all) experimental conditions [18,19].

3. The Behaviour of Normal Thyrocytes in Microgravity

The structural feature of the thyroid tissue is the thyroid follicle. These follicles are formed by the cells that produce the thyroid hormones triiodothyronine (T3) and thyroxine (T4) and are called follicular epithelial cells or thyrocytes. In vivo, the thyrocytes are arranged in a single layer (epithelium) and surround the lumen of the follicles. In cross sections, the follicles of the healthy thyroid gland are round or oval. Microgravity changes the thyroid follicles [20]. The follicles reveal larger thyrocytes and show an elevation of cyclic adenosine monophosphate (cAMP), thyrotropin-receptors and caveolin-1 [20,21]. Earlier in vitro and in vivo experiments demonstrated that thyrocytes respond to µg and hypergravity conditions [22,23,24,25,26]. Kossmehl et al. [23] showed that normal HTU-5 cells (obtained without transfection) [27] exposed to clinorotation revealed signs of apoptosis, as demonstrated by activation of caspase-3, increases in Fas and Bax and elevation of 85-kDa apoptosis-related cleavage fragments resulting from enhanced poly(ADP-ribose) polymerase activity. Apoptosis was found for various different cell types exposed to altered gravity conditions [28,29,30,31]. Results of the TEXUS (German: ‘Technologische EXperimente Unter Schwerelosigkeit’)-44 sounding rocket mission with FRTL-5 cells onboard showed that in real µg, normal thyroid cells do not respond to thyroid-stimulating hormone (TSH) treatment and present an irregular shape with condensed chromatin, a modification of the cell membrane with shedding of the TSH receptor in the supernatant, as well as elevated sphingomyelin-synthase and Bax protein [22]. With the help of a rotary cell culture system, differentiated thyroid neofollicles were located in close proximity after two weeks of culture [24]. A time-dependent increase in human thyroglobulin was detected in the cell culture supernatant. Exposure of thyrocytes in a rotary cell culture system under the presence of keratinocyte growth factor (KGF) allowed the formation of artificial human thyroid organoids. They structurally resembled natural thyroid tissue [24]. In addition, Nthy-ori 3-1 thyrocytes were able to form 3D spheroids when exposed to an FRC or an RPM [25]. This cell line was originally obtained from normal human primary thyrocytes transfected with a plasmid containing an origin-defective large T antigen SV40 genome [32]. Although Nthy-ori 3-1 cells remain non-tumorigenic, they possess a few specific features such as a strongly diminished thyroglobulin production and the presence of tri-tetraploid clones. Nthy-ori 3-1 cells were exposed for 24 h and 72 h to an RPM. After a 24-h RPM-exposure, they started to detach and to form 3D aggregates. The spheroids increased in number and size over time (72 h), while adherent cells decreased [26]. Nthy-ori 3-1 cells secreted various cytokines in connection with focal adhesion proteins and revealed positively or negatively interacting proteins, strengthening the onset of MCS formation. The interleukins (IL)-6, IL-8 and TIMP-1 seemed to be involved in this process [26]. Long-term RPM-exposure of Nthy-ori 3-1 cells demonstrated no signs of necrosis in the centre of the spheroids [6]. The non-malignant thyroid cells did not express receptors for vascular endothelial growth factor (VEGFRs) in a measurable amount [6] but they reacted with an up-regulation of downstream signalling molecules, which hinted either to a delayed reaction to the simulated µg or to further signalling molecules, which are involved in 3D-aggregate formation. The multipotent IL-6 could be a candidate that influences the cytoskeleton via β-actin [6]. IL-6 is known to be involved in angiogenesis and metastasis not only in thyroid cancer but also in several other cancer types. Elevated IL-6 concentrations could be explained by mechanically triggered activation of the specific surface receptor CD44 [33]. It was suggested that the CD44-IL-6-connection plays a possible role in gravity perception [6]. At least in pancreatic cancer cells, IL-6 stimulation activates the small GTPase cell division cycle 42 (Cdc42) and thus promotes the formation of pre-migratory, actin-based filopodia [34].
In summary, normal thyrocytes revealed changes in the cytoskeleton, shredding of their membranes, alterations in gene expression, protein synthesis and secretion and showed an increased amount of apoptosis and a change in growth behaviour.

4. Research on Thyroid Cancer Cells in Microgravity

Research on thyroid cancer cells using µg conditions became a more and more interesting topic [1]. Nearly 20 years of µg research in this field provided a deeper insight into the growth behaviour and signalling mechanisms of thyroid cancer (Figure 3). Since the first experiments in 2002, many studies have been conducted both in real and simulated µg environments using different model cell lines (ML-1, FTC-133 and UCLA RO-82W-1) and different research platforms (see also Figure 1).
  • Ground-Based Studies
Growth of 3D-aggregates (Figure 3 and Figure 4A) during random positioning was observed very early [35] and it was found that apoptosis is involved in MCS formation [23,36]. Programmed cell death of µg-exposed cells was also confirmed for other cell types [30,37]. In this setting, nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) was identified as a key player [37]. Furthermore, simulated µg affected gene expression patterns and the structure of the cytoskeleton already very early after exposure to µg [38,39]. In addition to alterations of the F-actin morphology (Figure 4B,C), 30 min of clinorotation induced a disorganization of vimentin, cytokeratin and microtubules. However, these changes were nearly reversed after 48 h [40]. This finding clearly supported the hypothesis that the cytoskeleton may sense gravity in eukaryotic cells [41]. µg also increased the amount of extracellular matrix (ECM) proteins in a time-dependent manner [40]. Based on the proteome data of different µg experiments, Bauer et al. [42] postulated that the stability of the ECM has a great influence on MCS formation under µg.
For scientists, it is very important to understand why and how MCS were formed. A 24 h-RPM-experiment with UCLA RO-82W-1 cells showed that genes of products involved in angiogenesis were up-regulated in MCS whereas gene products involved in ECM formation were down-regulated [43]. Especially FTC-133 follicular thyroid cancer cells formed larger and numerous spheroids compared to normal thyrocytes [6]. It is assumed that these cells express surface proteins that bind fibronectin, strengthening 3D cell cohesion [44]. An intense proteome analysis of FTC-133 cells to elucidate MCS formation revealed that paxillin, vinculin (Figure 4D,E) and focal adhesion kinase (FAK or PTK2) may be positioned within the focal adhesion complex in a way that favours cell detachment from the bottom of a culture flask and mutual attachment [45]. Caveolin-1 and connective tissue growth factor (CTGF) were down-regulated in spheroids [46].
Different transcription factors, especially the sex-determining region Y-related high-mobility group box (SOX) proteins, are deeply involved in cancer development and metastasis but for thyroid cancer only a few studies have addressed this topic so far. Also, the influence of µg on SOX expression is still unclear. In a first experiment, FTC-133 cells were analyzed after 10 days on the RPM. The cell line did not express SOX2, SOX5, SOX6 and SOX7 but was positive for SOX9 and SOX11. RPM-exposure had only a marginal effect on the expression of the SOX genes both in adherently growing cells and in the MCS cells [47].
  • Parabolic and Sounding Rocket Flights
Alternating phases of real µg (ca. 22 s), hypergravity and normal gravity during a parabolic flight provide optimal conditions for investigating morphological and genetic alterations directly in the transition from hypergravity to µg. A parabolic flight changed the morphology of the F-actin/cytokeratin cytoskeleton of ML-1 cells as well as the expression status of genes involved in forming the cytoskeleton and ECM [39]. Interestingly, the gene expression during the parabolic flight (and thus several changes in gravity conditions) was often regulated in the opposite direction compared to the RPM or space [48].
Several sounding-rocket flights allowed further short-term experiments in real µg (about 6 min) during the last years. The focus of these analyses was the very early mechanisms of cells exposed to real µg aiming to detect the first steps that later lead to cell detachment and MCS formation. FTC-133 cells expressing the LifeAct-GFP marker protein for the visualization of F-actin were flown on TEXUS-52 in 2015 and observed with live-cell imaging using the confocal FLUMIAS (Fluorescence-Microscopic Analysis Systems for Space Application) microscope. They proved significant structural alterations of the actin cytoskeleton as well as effects on the gene expression of genes involved in cytoskeleton forming (EZR) and signalling (SEPT11) [49]. With the THYROID project on the TEXUS-53 mission in 2016, Kopp et al. [50] investigated the effects of short-term µg and hypergravity on the transcriptome and proteome of FTC-133 cells. They identified a possible role of epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF) for spheroid formation in µg. In addition, they found that µg is a stronger regulator of gene expression than hypergravity, which shortly occurs during the launch of the rocket [51].
  • Space Missions
The long-term experiments in real µg provided a deeper insight into the growth behaviour of thyroid cancer cells in weightlessness excluding any additional shear forces as they might be induced in ground-based facilities. This helped to evaluate whether µg was the trigger for the effects observed in RPM experiments on Earth. After the SimBox/Shenzhou-8 mission in 2011, it became clear that space-flown follicular thyroid cancer cells changed their proliferation, cell adhesion, growth behaviour, and the post-flight results indicated that the cells shifted toward a less-aggressive phenotype [48]. Another interesting finding was that the confluence status of a cell culture could influence MCS formation. Preincubation of FTC-133 cells for five days before exposure to µg during the CellBox-1 mission completely inhibited the spheroid formation suggesting that the cell density together with high amounts of ECM proteins and caveolin-1 are of great importance for 3D growth [52,53]. The CellBox-2 mission in 2017 allowed to investigate the effects of real µg on the transcriptome and proteome of FTC-133 cells. The cells formed MCS in space and interestingly, these spheroids differed from MCS generated on an RPM by an enhanced release of VEGF [54]. As VEGF has a key role in neoangiogenesis, the enhanced production suggests a different angiogenic potential of thyroid cancer cells in space.
  • Supporting Semantic Analyses
Genomic and proteomic analyses performed after exposing healthy and malignant thyroid cells to devices simulating µg or to space or orbit flights unveiled a number of genes and proteins, which may play a role when the cells adapt to µg [55,56,57]. Semantic analyses of these genes and proteins enabled the identification of groups of interacting cellular entities and members of distinct pathways [58,59]. A group of gravisensitive genes was detected, which altered their transcription when exposed to µg. They code for proteins, which are either secreted into the culture supernatant, inserted in the cell membrane or located within the cytoplasm. Within the first 24 h of culturing the cells on an RPM, genes coding for secreted proteins were up-regulated but those coding for membrane or cytoplasmic proteins were down-regulated. After prolonged incubation, up-regulation of genes coding for membrane and cytoplasm proteins was also observed. According to information retrievable from the literature, these proteins form a network of interaction. They can either mutually influence their gene expression, form complexes or regulate their activity. Interestingly, this interaction network not only includes the products of gravisensitive genes but it also comprises proteins detected in culture supernatants by multianalyte profiling technology upon the cells’ exposure to µg [6,25,43,52].
Another group of related proteins was found when a deep proteome analysis was evaluated. This analysis was performed comparatively on thyroid FTC-133 cells, which were either incubated under normal gravity conditions or on the RPM, where they were split into two populations, one continuing to grow adherently, while the other one started to grow within a 3D aggregate. The evaluation showed 104 proteins of the integrin signalling pathway. In cells forming 3D aggregates during three days of culture on the RPM, the levels of caveolin-1 and p130cas proteins were reduced but arf-GAP with SH3 domain (ASAP1) production was enhanced. The results confirmed that caveolin-1 plays an important role in spheroid formation [52] and challenged the speculation that the positions of the proteins paxillin, vinculin and focal adhesion kinase may be changed by µg within the focal adhesion complex in a way that favours cell detachment from the bottom of a culture flask. Preliminary hints towards a µg-dependent change of intracellular vinculin distribution had already been observed during a recent TEXUS flight [45,51]. Taking together, in vitro studies on thyroid cells exposed to microgravity suggested that groups of proteins are affected by µg which interact over the membrane barrier and provided first insights in the mechanisms of tissue cells leaving the site of growth to migrate to another one as observed in metastasis [60].

4.1. Spheroids as a 3D Tumour Model

Both thyroid cancer cells and normal thyrocytes formed MCS [43,61], when they were cultivated in (simulated) µg. Follicular thyroid cancer cells detached from the cell culture flask bottom and assembled to compact 3D aggregates within a short time [35]. The tumour MCS were described to mimic small metastases that are not as complex as the primary tumour but could resemble a part of their organ of origin, reflecting a pathophysiological ‘inside-out’ situation (Figure 5) [62]. The ECM of MCS differed in amount and composition from the corresponding monolayer cultures comprising a complex 3D network of cell-cell and cell-matrix interactions. These differences might facilitate the penetration and action of drugs and affect the distribution and function of other physiological molecules such as hormones and growth factors. Thus, the composition of MCS fundamentally determines the regulation of cell growth, differentiation and apoptosis [62].
An important task is to clarify the mechanisms for spheroid formation. Several factors are involved in this process in addition to their role in metastasis and spreading of cancer cells in vivo (Table 1 and Table 2). Some of these factors may serve as future targets in cancer therapy.
An interesting finding was that caveolin-1 is a key factor for the inhibition of spheroid formation when confluent monolayers are exposed to µg [52]. The results of a pathway analysis using the data of these articles (Table 1) are given in Figure 6.
Ten of numerous studies on the behaviour of thyroid cells revealed proteins and genes coding for proteins that appear to be key proteins in spheroid formation. The studies were performed at very different time points on different populations of thyroid cells, culturing the cells either on an RPM, a clinostat or in space. The 31 proteins recognized as being important in MCS formation were, besides copine-1, all members of the networks of interaction according to the literature evaluated by the Elsevier Pathway Studio.
As demonstrated in Figure 6, various factors are involved in the formation of spheroids. The next step would be to study them in more detail. A first step was done by targeting E-cadherin in MCF-7 breast cancer cells [65]. The proto-oncogene tyrosine-protein kinase c-Src was detected in MCF-7 MCS. Anti-E-cadherin antibodies had enhanced the amount of MCS. The agent PP2, blocking the E-cadherin reducer SRC, prevented MCS formation completely [65].
Figure 6A,B show protein interaction networks. Looking at the mutual regulation of the proteins, it can be seen that 29 proteins form a network influencing the activity of each other (see Figure 6A). In most cases, the influence is stimulating (green arrows). Only a few red lines with little perpendicular bars at their ends indicate inhibition. PTK2, the focal adhesion kinase, seems to play a central role in this system, as most of the arrows point to its icon. As the icon of VEGF-A is a starting point for a considerable number of green arrows, one may conclude that VEGF-A is a strong initiator of spheroid formation. Interestingly, 21 of the proteins investigated bind physically to each other forming complexes (connecting lines) or triggering the partner’s activity (green arrows) (Figure 6B). In two cases, TIMP1-MMP2 and CAV1-KDR inhibition were indicated (red lines with the perpendicular bar at the side of inhibited protein). In this system of binding, fibronectin seems to play a central role.
Figure 6C shows that 27 of the proteins recognized as being important in spheroid formation influence each other’s mRNA expression. As shown by the high number of arrows the mutual gene expression regulation is very intensive. Again, most proteins favoured the expression of the partner protein’s mRNA (green arrows). Still a considerable number inhibits (red line with perpendicular bar at the end). In this system VEGFA, KDR, IL6 and CXCL8 are indicated as dominant target genes as many arrows point to their icons. Noteworthy is that many green arrows start at the SPP1 icon. This suggests that osteopontin is a major trigger of spheroid formation.
Figure 7 provides a comparative overview of the current cell (culture) models used for cancer research. It visualizes possibilities and limits of the different model types including µg-grown tumour spheroids. The µg-based method is able to provide a large number of MCS in a short time and is suitable for long-term experiments (no necrotic cores) as well as for cocultures. MCS were used for a variety of experimental studies using radiotherapy, chemotherapy, radioimmunotherapy, cell- and antibody-based immunotherapy, hyperthermia, gene therapy and photodynamic treatment [66]. Further, they serve as an invaluable experimental and theoretical model for basic research on proliferation, viability, energy metabolism, nutrient metabolism, invasion, cell-cell interactions and extracellular matrix composition helping to better estimate in vivo antitumor treatment modalities [66]. But although thyroid cancer cells grow in 3D structures in µg, MCS do not possess blood vessels that can provide oxygen and nutrients. Therefore, the MCS size remains limited.

4.2. Growth of Thyroid Cancer Cells in Microgravity–A Temporary Mimicry of Metastasis?

When a (progressive) tumour spreads from its primary site to another part of the organism this process is called metastasis. Metastatic cancer is characterized by the same type of cancer cells as the primary cancer. The tumour starts to extend and invades into the structures and tissues in its surrounding area. The first description of a thyroid metastasis was made by Rudolf Virchow in 1871, who found metastatic thyroid cells inside a testis [67]. Thyroid cancer mostly spreads to the lymph nodes, lungs, bone and occasionally to the brain. Follicular thyroid cancer tends to spread to distant sites via the blood vessels (hematogenously), as opposed to papillary thyroid cancer, which metastasizes through the lymphatic system (lymphogenously), usually to local lymph nodes. As angioinvasion is associated with the risk of recurrence, the differentiation of lymphatic and angioinvasion is of high importance [68]. Survival and growth of metastases at the new sites needs angiogenesis: The tumour forms a new blood supply by building new blood vessels. Metastasis is responsible for more than 90% of all the cancer-associated deaths. Approximately 30% of patients suffering from thyroid cancer develop metastases [69] and the incidence of distant metastasis after thyroidectomy remains between 7% and 23% [70]. In rare cases metastasis is associated with malignant ascites (especially described for medullary thyroid cancer [71]). Metastatic ascites containing multicellular spheroids can promote chemo-resistance and recurrence [72]. Model mechanisms relating to how single cells aggregate to form MCS once detached are important. MCS have been used in developmental biology and experimental cancer research for many years [73]. They are used as in vitro models of tumour microregions and as early avascular stage of tumour growth [62,66,74].
Progression and aggression of cancer are known to be closely connected to mechanical stress [75] resulting in alterations of cytoskeletal structures, cellular shape, proliferation, differentiation, cell adhesion, survival/death and migration [76,77]. The loss of gravity can also be a stressor for adherently growing cells that may be induced by tensegrity (tensional integrity) after gravitational unloading [78,79]. Interestingly, there are many parallels between the detachment of single cells from the primary tumour during metastasis and the detachment of adherently growing cells in µg (Table 3). Whereas metastasis is forced, among other factors, by the external pressure from the growing tumour [76], a possible physical trigger for cell detachment in µg is the lapse of gravity.
Research using MCS focused on mechanisms involved in proliferation, invasion and metastasis. µg conditions have been shown to induce 3D growth of benign and malignant cells [72]. A great advantage of µg-engineered MCS is that they do not develop a necrotic centre when cultured for several weeks [6,80]. Interestingly, results hint to a re-differentiation of follicular thyroid cancer cells in space to a less-aggressive phenotype (see chapter 4.4.) [48]. These findings are supported by recent data obtained with melanoma cells types exposed to µg. BL6-10 cells did not form multicellular spheroids but revealed comparable results, as clinostat-simulated µg reduced proliferation, adhesion and invasiveness in vitro and decreased tumour lung metastasis in vivo. Clinorotation also down-regulated metastasis-related integrin α6β4, MMP9 and Met72 molecules. Further, it significantly reduced the formation of focal adhesions and activation of the focal adhesion kinase (FAK), Rho family proteins (RhoA, Rac1 and Cdc42) and mTORC1 kinase but activated AMPK and ULK1 kinases [81]. Clinostat-exposure of the cells inhibited focal adhesions and induced inhibition of FAK and RhoA signalling and the mTORC1 pathway, which resulted in the activation of the AMPK pathway and thus reducing melanoma cell proliferation and metastasis. µg further changed the cytoskeleton and nuclear positioning, leading to enhanced cell apoptosis by suppressing the FAK/RhoA-regulated mTORC1/NFκB and ERK1/2 pathways [82]. Similar data were found by Grosse et al. [61] investigating follicular thyroid cancer (FTC-133) cells. Especially invasive follicular thyroid cancer is known to show an extensive vascular invasion [68]. FTC-133 cells grown on the RPM showed higher levels of NFκB p65 protein and apoptosis than controls grown under normal gravity (1g), a result also found earlier in endothelial cells [31]. IL6, CXCL8, CD44 and SPP1 were significantly up-regulated in adherent cells but not in MCS, while ERK1/2, CAV2, TLN1 and CTGF were significantly down-regulated in adherent cells. Simultaneously, the expression of ERK2, IL6, CAV2, TLN1 and CTGF was reduced in 3D MCS compared to 1g samples. The signalling elements IL-6, IL-8, OPN, TLN1 and CTGF were involved together with NF-κB p65 in the RPM-dependent thyroid carcinoma cell MCS formation. Similar findings were reported with glioma cells exposed to µg [83]. Simulated µg induced apoptosis of U251 cells. The FAK/RhoA/Rock and FAK/Nek2 signalling events were attenuated by simulated µg to destabilize the actin cytoskeleton and centrosome disjunction, which caused G2/M arrest and inhibition of cell viability and migration [83]. The FAK/RhoA/Rock and FAK/Nek2 pathways are affected by simulated µg and might serve as future targets. In addition, an earlier study showed that simulated µg reduced the metastatic potential of human lung adenocarcinoma cells by diminishing the expression of antigen MKI67 and MMP2, thereby inhibiting cell proliferation, migration and invasion [84]. In addition, MMP2 was reduced in the thyroid cancer space samples [48], supporting the results of Chang et al. [84] that simulated µg exerts an antiproliferative effect on lung cancer cells.

4.3. Reduced Aggressiveness of Thyroid Cancer Cells after Long-Term Exposure to Real Microgravity

When thyroid cancer cells had been examined after cultivation on an RPM at various time-points results suggested that µg initiated a re-differentiation of dedifferentiated FTC-133 cells after long-term RPM-exposure (Figure 8) [6]. The exact mechanisms behind this transformation are still unknown. After 7 and 14 days, expression of angiogenic factors like VEGF-A was significantly down-regulated, whereas the expression of apoptotic factors was increased. This suggested that exposure to simulated µg enabled selective programmed cell death, which identified the cells more differentiated compared to those grown under normal conditions [6]. Similar results were obtained from the SimBox/Shenzhou-8 mission when FTC-133 cells were cultured on an unmanned spacecraft for two weeks. Space-flown cells were shifted towards a less-malignant phenotype by down-regulation of VEGFA and up-regulation of VEGFD and IL15 [48]. IL6, CXCL8, SPP1, PRKAA and PRKCA mRNAs were all reduced both in adherent cells and MCS grown in space. As VEGF-A was found increased and VEGF-D serum levels were reported to be reduced in patients suffering from high-stage thyroid cancer [93,94], the authors concluded that µg possibly triggers some antitumor pathways involving IL-15 [48]. Consistent with these results a down-regulation of VEGFA was also found in the space-flown cells after the CellBox-2 mission, whereas the mRNA level of VEGFA stayed rather constant during a respective RPM experiment [54]. This VEGF discrepancy was often observed when results of simulated µg experiments were compared with data from real µg studies. Here it should be noted that VEGF gene expression is also up-regulated by the cells as a result of mechanical stress. It may be that fluid shear stress caused by random positioning [19,95,96] contributed to higher VEGFA mRNA levels of the RPM samples. In contrast to the space studies, the short-term exposure to real µg during a parabolic flight suggested an increased malignancy of the FTC-133 cells [48].

4.4. Drug Targeting

Using proteome analysis, Pietsch et al. [97] were able to detect the expression of 37 proteins previously not found in thyroid cells. Of special interest is the plastin-2, which plays a crucial role in the development of thyroid tumours, as well as the interferon-induced 17 kDa protein precursor, which is coded by the ISG15 gene [42]. This protein may be conjugated to target proteins by the E1 and E2 enzymes. Of the more than 150 yet known target proteins [98], we found 71 in the thyroid cells investigated [42]. During incubation on the RPM the protein’s accumulation decreased [45,56]. However, when mRNA expression was analyzed, after thyroid cells had been cultured for 10 days in space or on the RPM, a considerable up-regulation of the gene expression was observed [42,48,63]. ISG15 plays a role in antiviral immunity [99]. Recently a drug (Q63) was described, which exerted antiviral activity by down-regulation of ISG15 [100]. Even in cancer research ISG15 has attracted attention. It was recognized to be a prognostic marker in human breast cancer [101]. Studies on MCF7 cells suggested that the protein plays a role in stabilization of MCS generated on an RPM [65]. How the latter findings apply to thyroid cancer remains to be determined.
Bauer et al. [59] detected 69 proteins, which are significantly accumulated in thyroid cancer cells in the transition from 2D cell growth in normal gravity to spheroid growth in µg. These factors seem to be part of an overarching mechanism and therefore they are very interesting candidates for targeted tumour therapy. Reduction or inhibition of metastasis by knock-down or knock-out of one of these factors would decisively improve cancer therapy as well as patient survival. After the exploratory phase researchers have now begun with the functional analysis of previously detected genes. Using pharmacological targeting or silencing of individual genes, they are able to inhibit selected signalling pathways. MCF-7 breast cancer cells which were incubated with the NFκB inhibitor dexamethasone showed dose-dependent inhibition of spheroid formation [37]. The artificial glucocorticoid dexamethasone functionally inhibits NFκB and NFκB-dependent gene expression. Based on these results in µg research, it was proved that NFκB plays a crucial role in spheroid formation in breast cancer tumours. Further studies with the Src inhibitor PP2 and an anti-E-cadherin antibody also showed an influence on the spheroid formation of MCF-7 cells [65]. While the presence of PP2 completely inhibited spheroids, the E-cadherin antibody stimulated the formation of 3D structures. Both drugs had no effect on cell viability and all cells survived after pharmacological intervention. Similar attempts are planned for thyroid cancer research in the near future. The pharmacological substances that appear to be suitable are listed in Table 4.

5. Summary and Perspectives

Microgravity alters growth, cell adhesion, migration, proliferation, the cytoskeleton, extracellular matrix and focal adhesion of human cells in vitro. A large number of differentially regulated genes and altered protein synthesis and secretion are detectable in benign and malignant cells exposed to real or simulated µg. The model system ‘Multicellular Spheroid’ is suitable to mimic metastasis of solid tumours and can be used for drug testing in pharmacology or as a coculture model to study processes like metastasis or angiogenesis. The investigation of the underlying mechanisms of spheroid formation also delivers valuable information about the in vivo cancer progression and metastasis.
Research in the fields of space medicine and gravitational biology makes it possible to find new proteins in organ tissues and changes in protein synthesis and secretion. Altered gravity conditions provide a new technology which is helpful to detect changes in proteins which may represent new targets for drug development in cancer. A large number of proteins which may serve as promising targets and available drugs are listed in Table 4. In order to address cancer growth and regulation, further µg studies should be performed. We recently investigated changes of SOX transcription factors on FTC-133 follicular thyroid cancer cells exposed to the RPM and determined the mRNA expression of SOX9 and SOX11 in adherently growing and MCS cells [47]. The SOX family is involved in the progression and metastasis of cancer cells. Its expression in thyroid cancer is not clarified until today and requires further investigation. Studies focusing on the role of SOX family members and in particular the SoxF group in radioactive iodine-refractory differentiated thyroid cancer cells are of high interest. Recent results in the field of cancer research in µg taught us that focal adhesions play an important role in the inhibition of proliferation and metastasis in melanoma cells [81]. Therefore, intensive research in thyroid cancer investigating focal adhesions should be performed in µg by applying live-cell imaging with the FLUMIAS microscope [49] onboard the ISS or on sounding rockets.
Microgravity research is just one part of cancer research but might enable a significant step toward better treatments. Some years ago, with the help of simulated µg various proteins were detected in thyroid tissue for the first time [97]. Some of them are targeted today. In addition, the compounds given in Table 4 are currently under investigation. The results may truly provide hope for thyroid cancer patients.

Author Contributions

All authors contributed to the review and searched literature. Conceptualization, M.K. and D.G.; Investigation, D.M., C.B., J.S. and T.J.C.; writing—original draft preparation, M.K., J.B. and D.G.; review and editing. M.K., D.G., R.H. and J.B.; visualization, M.K., J.B. and S.K.; project administration, D.G.; funding acquisition, D.G., M.I., R.H.

Funding

This research was funded by the German Space Agency (DLR, grants 50WB1124, 50WB1524 and 50WB1924), by the Otto von Guericke University Magdeburg, Germany and by the Aarhus University, Denmark.

Acknowledgments

We would like to thank Markus Braun and Michael Becker from the German Aerospace Center (DLR, Bonn) for supporting our studies for many years. We also thank the engineers of Airbus Defence and Space for developing the perfect hardware for our spaceflights and sounding rocket flights and for their wonderful support. Last but not least we would like to thank the team of PRS & EJE (Letchworth Garden City, UK) for academic proofreading of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

2DTwo-dimensional
3DThree-dimensional
ACTBβ-Actin
ADAdherent cells
AMPK5′Adenosine monophosphate-activated protein kinase
CAV1/2Caveolin-1, -2,
CD44Cluster of differentiation 44
CTGFConnective tissue growth factor
CXCLC-X-C motif
ECMExtracellular matrix
EGFEpidermal growth factor
ERK1/2Extracellular signal-regulated kinase 1,2
FGF17Fibroblast growth factor 17
FLK1Fetal liver kinase 1
FLUMIASFluorescence-microscopic analysis systems for space application
FLT1Fms-related tyrosine kinase 1
FN1Fibronectin
FRCFast-rotating clinostat
ILInterleukin
KDRKinase insert domain receptor
MCSMulticellular spheroid
MMPMatrix metalloproteinase
µgMicrogravity
Nek2Serine/threonine-protein kinase Nek2
NFκBNuclear factor κ-light-chain-enhancer of activated B cells
OPNOsteopontin
PRKAAProtein kinase, AMP-activated, α catalytic subunit
PRKCAProtein kinase Cα
RhoARas homolog gene family, member A
RPMRandom positioning machine
RWVRotating wall vessel
SOXSex determining region Y-related high-mobility group box proteins
TGF-βTransforming growth factor β
TIMP1Tissue inhibitor of metalloproteinases 1
TLN1Talin 1
TSHThyroid-stimulating hormone
TUBBβ-tubulin
VEGFVascular endothelial growth factor

References

  1. Becker, J.L.; Souza, G.R. Using space-based investigations to inform cancer research on earth. Nat. Rev. Cancer 2013, 13, 315–327. [Google Scholar] [CrossRef]
  2. Jhala, D.V.; Kale, R.K.; Singh, R.P. Microgravity alters cancer growth and progression. Curr. Cancer Drug Targets 2014, 14, 394–406. [Google Scholar] [CrossRef] [PubMed]
  3. Hammond, T.G.; Benes, E.; O’Reilly, K.C.; Wolf, D.A.; Linnehan, R.M.; Taher, A.; Kaysen, J.H.; Allen, P.L.; Goodwin, T.J. Mechanical culture conditions effect gene expression: Gravity-induced changes on the space shuttle. Physiol. Genom. 2000, 3, 163–173. [Google Scholar] [CrossRef] [PubMed]
  4. Duval, K.; Grover, H.; Han, L.-H.; Mou, Y.; Pegoraro, A.F.; Fredberg, J.; Chen, Z. Modeling physiological events in 2d vs. 3d cell culture. Physiology 2017, 32, 266–277. [Google Scholar] [CrossRef]
  5. Groebe, K.; Mueller-Klieser, W. On the relation between size of necrosis and diameter of tumor spheroids. Int. J. Radiat. Oncol. Biol. Phys. 1996, 34, 395–401. [Google Scholar] [CrossRef]
  6. Kopp, S.; Warnke, E.; Wehland, M.; Aleshcheva, G.; Magnusson, N.E.; Hemmersbach, R.; Corydon, T.J.; Bauer, J.; Infanger, M.; Grimm, D. Mechanisms of three-dimensional growth of thyroid cells during long-term simulated microgravity. Sci. Rep. 2015, 5, 16691. [Google Scholar] [CrossRef] [Green Version]
  7. Aleshcheva, G.; Bauer, J.; Hemmersbach, R.; Slumstrup, L.; Wehland, M.; Infanger, M.; Grimm, D. Scaffold-free tissue formation under real and simulated microgravity conditions. Basic Clin. Pharmacol. Toxicol. 2016, 119, 26–33. [Google Scholar] [CrossRef]
  8. Zanoni, M.; Piccinini, F.; Arienti, C.; Zamagni, A.; Santi, S.; Polico, R.; Bevilacqua, A.; Tesei, A. 3d tumor spheroid models for in vitro therapeutic screening: A systematic approach to enhance the biological relevance of data obtained. Sci. Rep. 2016, 6, 19103. [Google Scholar] [CrossRef]
  9. Al-Ramadan, A.; Mortensen, A.C.; Carlsson, J.; Nestor, M.V. Analysis of radiation effects in two irradiated tumor spheroid models. Oncol. Lett. 2018, 15, 3008–3016. [Google Scholar] [CrossRef] [PubMed]
  10. La Vecchia, C.; Malvezzi, M.; Bosetti, C.; Garavello, W.; Bertuccio, P.; Levi, F.; Negri, E. Thyroid cancer mortality and incidence: A global overview. Int. J. Cancer 2015, 136, 2187–2195. [Google Scholar] [CrossRef]
  11. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef]
  12. Albi, E.; Krüger, M.; Hemmersbach, R.; Lazzarini, A.; Cataldi, S.; Codini, M.; Beccari, T.; Ambesi-Impiombato, F.S.; Curcio, F. Impact of gravity on thyroid cells. Int. J. Mol. Sci. 2017, 18, 972. [Google Scholar] [CrossRef] [PubMed]
  13. Braddock, M. From target identification to drug development in space: Using the microgravity assist. Curr. Drug Discov. Technol. 2019. [Google Scholar] [CrossRef]
  14. Eiermann, P.; Kopp, S.; Hauslage, J.; Hemmersbach, R.; Gerzer, R.; Ivanova, K. Adaptation of a 2-d clinostat for simulated microgravity experiments with adherent cells. Microgravity Sci. Technol. 2013, 25, 153–159. [Google Scholar] [CrossRef]
  15. Klaus, D.M. Clinostats and bioreactors. Gravit. Space Biol. Bull. 2001, 14, 55–64. [Google Scholar]
  16. Borst, A.G.; van Loon, J.J.W.A. Technology and developments for the random positioning machine, rpm. Microgravity Sci. Technol. 2008, 21, 287. [Google Scholar] [CrossRef]
  17. van Loon, J.J.W.A. Some history and use of the random positioning machine, rpm, in gravity related research. Adv. Space Res. 2007, 39, 1161–1165. [Google Scholar] [CrossRef]
  18. Herranz, R.; Anken, R.; Boonstra, J.; Braun, M.; Christianen, P.C.; de Geest, M.; Hauslage, J.; Hilbig, R.; Hill, R.J.; Lebert, M.; et al. Ground-based facilities for simulation of microgravity: Organism-specific recommendations for their use and recommended terminology. Astrobiology 2013, 13, 1–17. [Google Scholar] [CrossRef]
  19. Wuest, S.L.; Richard, S.; Kopp, S.; Grimm, D.; Egli, M. Simulated microgravity: Critical review on the use of random positioning machines for mammalian cell culture. Biomed. Res. Int. 2015, 2015, 971474. [Google Scholar] [CrossRef]
  20. Albi, E.; Curcio, F.; Lazzarini, A.; Floridi, A.; Cataldi, S.; Lazzarini, R.; Loreti, E.; Ferri, I.; Ambesi-Impiombato, F.S. How microgravity changes galectin-3 in thyroid follicles. Biomed. Res. Int 2014, 2014, 5. [Google Scholar] [CrossRef]
  21. Masini, M.A.; Albi, E.; Barmo, C.; Bonfiglio, T.; Bruni, L.; Canesi, L.; Cataldi, S.; Curcio, F.; D’Amora, M.; Ferri, I.; et al. The impact of long-term exposure to space environment on adult mammalian organisms: A study on mouse thyroid and testis. PLoS ONE 2012, 7, e35418. [Google Scholar] [CrossRef] [PubMed]
  22. Albi, E.; Ambesi-Impiombato, F.S.; Peverini, M.; Damaskopoulou, E.; Fontanini, E.; Lazzarini, R.; Curcio, F.; Perrella, G. Thyrotropin receptor and membrane interactions in frtl-5 thyroid cell strain in microgravity. Astrobiology 2011, 11, 57–64. [Google Scholar] [CrossRef] [PubMed]
  23. Kossmehl, P.; Shakibaei, M.; Cogoli, A.; Infanger, M.; Curcio, F.; Schönberger, J.; Eilles, C.; Bauer, J.; Pickenhahn, H.; Schulze-Tanzil, G.; et al. Weightlessness induced apoptosis in normal thyroid cells and papillary thyroid carcinoma cells via extrinsic and intrinsic pathways. Endocrinology 2003, 144, 4172–4179. [Google Scholar] [CrossRef] [PubMed]
  24. Martin, A.; Zhou, A.; Gordon, R.E.; Henderson, S.C.; Schwartz, A.E.; Schwartz, A.E.; Friedman, E.W.; Davies, T.F. Thyroid organoid formation in simulated microgravity: Influence of keratinocyte growth factor. Thyroid 2000, 10, 481–487. [Google Scholar] [CrossRef]
  25. Warnke, E.; Kopp, S.; Wehland, M.; Hemmersbach, R.; Bauer, J.; Pietsch, J.; Infanger, M.; Grimm, D. Thyroid cells exposed to simulated microgravity conditions – comparison of the fast rotating clinostat and the random positioning machine. Microgravity Sci. Technol. 2016, 28, 247–260. [Google Scholar] [CrossRef]
  26. Warnke, E.; Pietsch, J.; Kopp, S.; Bauer, J.; Sahana, J.; Wehland, M.; Krüger, M.; Hemmersbach, R.; Infanger, M.; Lützenberg, R.; et al. Cytokine release and focal adhesion proteins in normal thyroid cells cultured on the random positioning machine. Cell Physiol. Biochem. 2017, 43, 257–270. [Google Scholar] [CrossRef] [PubMed]
  27. Curcio, F.; Ambesi-Impiombato, F.S.; Perrella, G.; Coon, H.G. Long-term culture and functional characterization of follicular cells from adult normal human thyroids. Proc. Natl. Acad. Sci. USA 1994, 91, 9004–9008. [Google Scholar] [CrossRef]
  28. Lewis, M.L.; Reynolds, J.L.; Cubano, L.A.; Hatton, J.P.; Lawless, B.D.; Piepmeier, E.H. Spaceflight alters microtubules and increases apoptosis in human lymphocytes (jurkat). FASEB J. 1998, 12, 1007–1018. [Google Scholar] [CrossRef]
  29. Uva, B.M.; Masini, M.A.; Sturla, M.; Bruzzone, F.; Giuliani, M.; Tagliafierro, G.; Strollo, F. Microgravity-induced apoptosis in cultured glial cells. Eur. J. Histochem. 2002, 46, 209–214. [Google Scholar] [CrossRef]
  30. Battista, N.; Meloni, M.A.; Bari, M.; Mastrangelo, N.; Galleri, G.; Rapino, C.; Dainese, E.; Agro, A.F.; Pippia, P.; Maccarrone, M. 5-lipoxygenase-dependent apoptosis of human lymphocytes in the international space station: Data from the roald experiment. FASEB J. 2012, 26, 1791–1798. [Google Scholar] [CrossRef]
  31. Infanger, M.; Kossmehl, P.; Shakibaei, M.; Baatout, S.; Witzing, A.; Grosse, J.; Bauer, J.; Cogoli, A.; Faramarzi, S.; Derradji, H.; et al. Induction of three-dimensional assembly and increase in apoptosis of human endothelial cells by simulated microgravity: Impact of vascular endothelial growth factor. Apoptosis 2006, 11, 749–764. [Google Scholar] [CrossRef] [PubMed]
  32. Lemoine, N.R.; Mayall, E.S.; Jones, T.; Sheer, D.; McDermid, S.; Kendall-Taylor, P.; Wynford-Thomas, D. Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40 DNA transfection. Br. J. Cancer 1989, 60, 897–903. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Vistejnova, L.; Safrankova, B.; Nesporova, K.; Slavkovsky, R.; Hermannova, M.; Hosek, P.; Velebny, V.; Kubala, L. Low molecular weight hyaluronan mediated cd44 dependent induction of il-6 and chemokines in human dermal fibroblasts potentiates innate immune response. Cytokine 2014, 70, 97–103. [Google Scholar] [CrossRef] [PubMed]
  34. Razidlo, G.L.; Burton, K.M.; McNiven, M.A. Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small gtpase cdc42. J. Biol. Chem. 2018, 293, 11143–11153. [Google Scholar] [CrossRef] [PubMed]
  35. Grimm, D.; Kossmehl, P.; Shakibaei, M.; Schulze-Tanzil, G.; Pickenhahn, H.; Bauer, J.; Paul, M.; Cogoli, A. Effects of simulated microgravity on thyroid carcinoma cells. Life Space Life Earth 2002, 501, 39–42. [Google Scholar]
  36. Kossmehl, P.; Shakibaei, M.; Cogoli, A.; Pickenhahn, H.; Paul, M.; Grimm, D. Simulated microgravity induces programmed cell death in human thyroid carcinoma cells. J. Gravit. Physiol. 2002, 9, 295–296. [Google Scholar] [PubMed]
  37. Kopp, S.; Sahana, J.; Islam, T.; Petersen, A.G.; Bauer, J.; Corydon, T.J.; Schulz, H.; Saar, K.; Huebner, N.; Slumstrup, L.; et al. The role of nfkappab in spheroid formation of human breast cancer cells cultured on the random positioning machine. Sci. Rep. 2018, 8, 921. [Google Scholar] [CrossRef]
  38. Infanger, M.; Kossmehl, P.; Shakibaei, M.; Schulze-Tanzil, G.; Cogoli, A.; Faramarzi, S.; Bauer, J.; Curcio, F.; Paul, M.; Grimm, D. Longterm conditions of mimicked weightlessness influences the cytoskeleton in thyroid cells. J. Gravit. Physiol. 2004, 11, P169–P172. [Google Scholar]
  39. Ulbrich, C.; Pietsch, J.; Grosse, J.; Wehland, M.; Schulz, H.; Saar, K.; Hübner, N.; Hauslage, J.; Hemmersbach, R.; Braun, M.; et al. Differential gene regulation under altered gravity conditions in follicular thyroid cancer cells: Relationship between the extracellular matrix and the cytoskeleton. Cell Physiol. Biochem. 2011, 28, 185–198. [Google Scholar] [CrossRef]
  40. Infanger, M.; Kossmehl, P.; Shakibaei, M.; Bauer, J.; Kossmehl-Zorn, S.; Cogoli, A.; Curcio, F.; Oksche, A.; Wehland, M.; Kreutz, R.; et al. Simulated weightlessness changes the cytoskeleton and extracellular matrix proteins in papillary thyroid carcinoma cells. Cell Tissue Res. 2006, 324, 267–277. [Google Scholar] [CrossRef]
  41. Vorselen, D.; Roos, W.H.; MacKintosh, F.C.; Wuite, G.J.; van Loon, J.J. The role of the cytoskeleton in sensing changes in gravity by nonspecialized cells. FASEB J. 2014, 28, 536–547. [Google Scholar] [CrossRef]
  42. Bauer, J.; Wehland, M.; Pietsch, J.; Sickmann, A.; Weber, G.; Grimm, D. Annotated gene and proteome data support recognition of interconnections between the results of different experiments in space research. Microgravity Sci. Technol. 2016, 28, 357–365. [Google Scholar] [CrossRef]
  43. Riwaldt, S.; Bauer, J.; Wehland, M.; Slumstrup, L.; Kopp, S.; Warnke, E.; Dittrich, A.; Magnusson, N.E.; Pietsch, J.; Corydon, T.J.; et al. Pathways regulating spheroid formation of human follicular thyroid cancer cells under simulated microgravity conditions: A genetic approach. Int. J. Mol. Sci. 2016, 17, 528. [Google Scholar] [CrossRef]
  44. Pietsch, J.; Sickmann, A.; Weber, G.; Bauer, J.; Egli, M.; Wildgruber, R.; Infanger, M.; Grimm, D. A proteomic approach to analysing spheroid formation of two human thyroid cell lines cultured on a random positioning machine. Proteomics 2011, 11, 2095–2104. [Google Scholar] [CrossRef]
  45. Bauer, J.; Kopp, S.; Schlagberger, E.M.; Grosse, J.; Sahana, J.; Riwaldt, S.; Wehland, M.; Luetzenberg, R.; Infanger, M.; Grimm, D. Proteome analysis of human follicular thyroid cancer cells exposed to the random positioning machine. Int. J. Mol. Sci. 2017, 18, 546. [Google Scholar] [CrossRef]
  46. Warnke, E.; Pietsch, J.; Wehland, M.; Bauer, J.; Infanger, M.; Görög, M.; Hemmersbach, R.; Braun, M.; Ma, X.; Sahana, J.; et al. Spheroid formation of human thyroid cancer cells under simulated microgravity: A possible role of ctgf and cav1. Cell Commun. Signal. 2014, 12, 32. [Google Scholar] [CrossRef]
  47. Grimm, D.; Bauer, J.; Wise, P.; Krüger, M.; Simonsen, U.; Wehland, M.; Infanger, M.; Corydon, T.J. The role of sox family members in solid tumours and metastasis. Semin. Cancer Biol. 2019. [Google Scholar] [CrossRef]
  48. Ma, X.; Pietsch, J.; Wehland, M.; Schulz, H.; Saar, K.; Hübner, N.; Bauer, J.; Braun, M.; Schwarzwälder, A.; Segerer, J.; et al. Differential gene expression profile and altered cytokine secretion of thyroid cancer cells in space. FASEB J. 2014, 28, 813–835. [Google Scholar] [CrossRef]
  49. Corydon, T.J.; Kopp, S.; Wehland, M.; Braun, M.; Schutte, A.; Mayer, T.; Hulsing, T.; Oltmann, H.; Schmitz, B.; Hemmersbach, R.; et al. Alterations of the cytoskeleton in human cells in space proved by life-cell imaging. Sci. Rep. 2016, 6, 20043. [Google Scholar] [CrossRef]
  50. Kopp, S.; Krüger, M.; Feldmann, S.; Oltmann, H.; Schütte, A.; Schmitz, B.; Bauer, J.; Schulz, H.; Saar, K.; Huebner, N.; et al. Thyroid cancer cells in space during the TEXUS-53 sounding rocket mission-the thyroid project. Sci. Rep. 2018, 8, 10355. [Google Scholar] [CrossRef]
  51. Kopp, S.; Krüger, M.; Bauer, J.; Wehland, M.; Corydon, T.J.; Sahana, J.; Nassef, M.Z.; Melnik, D.; Bauer, T.J.; Schulz, H.; et al. Microgravity affects thyroid cancer cells during the TEXUS-53 mission stronger than hypergravity. Int. J. Mol. Sci. 2018, 19, 4001. [Google Scholar] [CrossRef] [PubMed]
  52. Riwaldt, S.; Bauer, J.; Pietsch, J.; Braun, M.; Segerer, J.; Schwarzwälder, A.; Corydon, T.J.; Infanger, M.; Grimm, D. The importance of caveolin-1 as key-regulator of three-dimensional growth in thyroid cancer cells cultured under real and simulated microgravity conditions. Int. J. Mol. Sci. 2015, 16, 28296–28310. [Google Scholar] [CrossRef]
  53. Riwaldt, S.; Pietsch, J.; Sickmann, A.; Bauer, J.; Braun, M.; Segerer, J.; Schwarzwälder, A.; Aleshcheva, G.; Corydon, T.J.; Infanger, M.; et al. Identification of proteins involved in inhibition of spheroid formation under microgravity. Proteomics 2015, 15, 2945–2952. [Google Scholar] [CrossRef]
  54. Melnik, D.; Krüger, M.; Kopp, S.; Wehland, M.; Bauer, J.; Infanger, M.; Grimm, D. Microgravity-based modulation of VEGF expression in human thyroid carcinoma cells. Front. Physiol. 2019, 9. [Google Scholar] [CrossRef]
  55. Pietsch, J.; Riwaldt, S.; Bauer, J.; Sickmann, A.; Weber, G.; Grosse, J.; Infanger, M.; Eilles, C.; Grimm, D. Interaction of proteins identified in human thyroid cells. Int. J. Mol. Sci. 2013, 14, 1164–1178. [Google Scholar] [CrossRef] [PubMed]
  56. Pietsch, J.; Bauer, J.; Weber, G.; Nissum, M.; Westphal, K.; Egli, M.; Grosse, J.; Schönberger, J.; Eilles, C.; Infanger, M.; et al. Proteome analysis of thyroid cancer cells after long-term exposure to a random positioning machine. Microgravity Sci. Technol. 2011, 23, 381–390. [Google Scholar] [CrossRef]
  57. Pietsch, J.; Sickmann, A.; Weber, G.; Bauer, J.; Egli, M.; Wildgruber, R.; Infanger, M.; Grimm, D. Metabolic enzyme diversity in different human thyroid cell lines and their sensitivity to gravitational forces. Proteomics 2012, 12, 2539–2546. [Google Scholar] [CrossRef] [PubMed]
  58. Bauer, J.; Grimm, D.; Gombocz, E. Semantic analysis of thyroid cancer cell proteins obtained from rare research opportunities. J. Biomed. Inform. 2017, 76, 138–153. [Google Scholar] [CrossRef]
  59. Bauer, J.; Wehland, M.; Infanger, M.; Grimm, D.; Gombocz, E. Semantic analysis of posttranslational modification of proteins accumulated in thyroid cancer cells exposed to simulated microgravity. Int. J. Mol. Sci. 2018, 19, 2257. [Google Scholar] [CrossRef]
  60. Bauer, J.; Cohly, H.H.P.; Sahana, J.; Grimm, D. Preparative enrichment of human tissue cells capable to change a site of growth in vitro or in vivo-recent developments. Prep. Biochem. Biotechnol. 2018, 48, 954–960. [Google Scholar] [CrossRef]
  61. Grosse, J.; Wehland, M.; Pietsch, J.; Schulz, H.; Saar, K.; Hübner, N.; Eilles, C.; Bauer, J.; Abou-El-Ardat, K.; Baatout, S.; et al. Gravity-sensitive signaling drives 3-dimensional formation of multicellular thyroid cancer spheroids. FASEB J. 2012, 26, 5124–5140. [Google Scholar] [CrossRef]
  62. Kunz-Schughart, L.A. Multicellular tumor spheroids: Intermediates between monolayer culture and in vivo tumor. Cell Biol. Int. 1999, 23, 157–161. [Google Scholar] [CrossRef]
  63. Pietsch, J.; Ma, X.; Wehland, M.; Aleshcheva, G.; Schwarzwälder, A.; Segerer, J.; Birlem, M.; Horn, A.; Bauer, J.; Infanger, M.; et al. Spheroid formation of human thyroid cancer cells in an automated culturing system during the shenzhou-8 space mission. Biomaterials 2013, 34, 7694–7705. [Google Scholar] [CrossRef]
  64. Svejgaard, B.; Wehland, M.; Ma, X.; Kopp, S.; Sahana, J.; Warnke, E.; Aleshcheva, G.; Hemmersbach, R.; Hauslage, J.; Grosse, J.; et al. Common effects on cancer cells exerted by a random positioning machine and a 2d clinostat. PLoS ONE 2015, 10, e0135157. [Google Scholar] [CrossRef]
  65. Sahana, J.; Nassef, M.Z.; Wehland, M.; Kopp, S.; Krüger, M.; Corydon, T.J.; Infanger, M.; Bauer, J.; Grimm, D. Decreased e-cadherin in mcf7 human breast cancer cells forming multicellular spheroids exposed to simulated microgravity. Proteomics 2018, 18, e1800015. [Google Scholar] [CrossRef]
  66. Kunz-Schughart, L.A.; Freyer, J.P.; Hofstaedter, F.; Ebner, R. The use of 3-d cultures for high-throughput screening: The multicellular spheroid model. J. Biomol. Screen 2004, 9, 273–285. [Google Scholar] [CrossRef]
  67. Willis, R.A. Metastatic tumours in the thyreoid gland. Am. J. Pathol. 1931, 7, 187–208.183. [Google Scholar]
  68. Schmidbauer, B.; Menhart, K.; Hellwig, D.; Grosse, J. Differentiated thyroid cancer-treatment: State of the art. Int. J. Mol. Sci. 2017, 18, 1292. [Google Scholar] [CrossRef]
  69. Wang, L.Y.; Palmer, F.L.; Nixon, I.J.; Thomas, D.; Patel, S.G.; Shaha, A.R.; Shah, J.P.; Tuttle, R.M.; Ganly, I. Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer. Thyroid 2014, 24, 1594–1599. [Google Scholar] [CrossRef]
  70. Parameswaran, R.; Shulin Hu, J.; Min En, N.; Tan, W.B.; Yuan, N.K. Patterns of metastasis in follicular thyroid carcinoma and the difference between early and delayed presentation. Ann. R. Coll. Surg. Engl. 2017, 99, 151–154. [Google Scholar] [CrossRef] [Green Version]
  71. Rosa, M. Cytological features of medullary thyroid carcinoma in ascitic effusion. Diagn Cytopathol. 2017, 45, 1030–1032. [Google Scholar] [CrossRef]
  72. Al Habyan, S.; Kalos, C.; Szymborski, J.; McCaffrey, L. Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer. Oncogene 2018, 37, 5127–5135. [Google Scholar] [CrossRef]
  73. Mueller-Klieser, W. Multicellular spheroids. A review on cellular aggregates in cancer research. J. Cancer Res. Clin. Oncol. 1987, 113, 101–122. [Google Scholar] [CrossRef]
  74. Hamilton, G. Multicellular spheroids as an in vitro tumor model. Cancer Lett. 1998, 131, 29–34. [Google Scholar] [CrossRef]
  75. Northcott, J.M.; Dean, I.S.; Mouw, J.K.; Weaver, V.M. Feeling stress: The mechanics of cancer progression and aggression. Front. Cell Dev. Biol. 2018, 6, 17. [Google Scholar] [CrossRef]
  76. Butcher, D.T.; Alliston, T.; Weaver, V.M. A tense situation: Forcing tumour progression. Nat. Rev. Cancer 2009, 9, 108–122. [Google Scholar] [CrossRef]
  77. Yu, H.; Mouw, J.K.; Weaver, V.M. Forcing form and function: Biomechanical regulation of tumor evolution. Trends Cell Biol. 2011, 21, 47–56. [Google Scholar] [CrossRef]
  78. Ingber, D.E.; Wang, N.; Stamenovic, D. Tensegrity, cellular biophysics and the mechanics of living systems. Rep. Prog. Phys. 2014, 77, 046603. [Google Scholar] [CrossRef]
  79. Ingber, D. How cells (might) sense microgravity. FASEB J. 1999, 13, 3–15. [Google Scholar] [CrossRef]
  80. Dittrich, A.; Grimm, D.; Sahana, J.; Bauer, J.; Krüger, M.; Infanger, M.; Magnusson, N.E. Key proteins involved in spheroid formation and angiogenesis in endothelial cells after long-term exposure to simulated microgravity. Cell Physiol. Biochem. 2018, 45, 429–445. [Google Scholar] [CrossRef]
  81. Tan, X.; Xu, A.; Zhao, T.; Zhao, Q.; Zhang, J.; Fan, C.; Deng, Y.; Freywald, A.; Genth, H.; Xiang, J. Simulated microgravity inhibits cell focal adhesions leading to reduced melanoma cell proliferation and metastasis via fak/rhoa-regulated mtorc1 and ampk pathways. Sci. Rep. 2018, 8, 3769. [Google Scholar] [CrossRef] [PubMed]
  82. Zhao, T.; Li, R.; Tan, X.; Zhang, J.; Fan, C.; Zhao, Q.; Deng, Y.; Xu, A.; Lukong, K.E.; Genth, H.; et al. Simulated microgravity reduces focal adhesions and alters cytoskeleton and nuclear positioning leading to enhanced apoptosis via suppressing fak/rhoa-mediated mtorc1/nf-kappab and ERK1/2 pathways. Int. J. Mol. Sci. 2018, 19, 1994. [Google Scholar] [CrossRef]
  83. Deng, B.; Liu, R.; Tian, X.; Han, Z.; Chen, J. Simulated microgravity inhibits the viability and migration of glioma via fak/rhoa/rock and fak/nek2 signaling. In Vitro Cell Dev. Biol. Anim. 2019, 55, 260–271. [Google Scholar] [CrossRef] [PubMed]
  84. Chang, D.; Xu, H.; Guo, Y.; Jiang, X.; Liu, Y.; Li, K.; Pan, C.; Yuan, M.; Wang, J.; Li, T.; et al. Simulated microgravity alters the metastatic potential of a human lung adenocarcinoma cell line. In Vitro Cell Dev. Biol. Anim. 2013, 49, 170–177. [Google Scholar] [CrossRef] [PubMed]
  85. Yamaguchi, H.; Condeelis, J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim. Biophys. Acta 2007, 1773, 642–652. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Ding, Z.; Joy, M.; Bhargava, R.; Gunsaulus, M.; Lakshman, N.; Miron-Mendoza, M.; Petroll, M.; Condeelis, J.; Wells, A.; Roy, P. Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis. Oncogene 2014, 33, 2065–2074. [Google Scholar] [CrossRef]
  87. Miao, J.W.; Liu, L.J.; Huang, J. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma. Int. J. Oncol. 2014, 45, 165–176. [Google Scholar] [CrossRef]
  88. Klassen, L.M.B.; Chequin, A.; Manica, G.C.M.; Biembengut, I.V.; Toledo, M.B.; Baura, V.A.; de, O.P.F.; Ramos, E.A.S.; Costa, F.F.; de Souza, E.M.; et al. Mmp9 gene expression regulation by intragenic epigenetic modifications in breast cancer. Gene 2018, 642, 461–466. [Google Scholar] [CrossRef]
  89. Wai, P.Y.; Kuo, P.C. Osteopontin: Regulation in tumor metastasis. Cancer Metastasis Rev. 2008, 27, 103–118. [Google Scholar] [CrossRef]
  90. Luca, M.; Huang, S.; Gershenwald, J.E.; Singh, R.K.; Reich, R.; Bar-Eli, M. Expression of interleukin-8 by human melanoma cells up-regulates mmp-2 activity and increases tumor growth and metastasis. Am. J. Pathol. 1997, 151, 1105–1113. [Google Scholar]
  91. Liu, W.; Xu, J.; Wang, M.; Wang, Q.; Bi, Y.; Han, M. Tumor-derived vascular endothelial growth factor (vegf)-a facilitates tumor metastasis through the vegf-vegfr1 signaling pathway. Int. J. Oncol. 2011, 39, 1213–1220. [Google Scholar] [CrossRef] [PubMed]
  92. Sottnik, J.L.; Theodorescu, D. Cd44: A metastasis driver and therapeutic target. Oncoscience 2016, 3, 320–321. [Google Scholar] [CrossRef] [PubMed]
  93. Nersita, R.; Matrone, A.; Klain, M.; Scavuzzo, F.; Vitolo, G.; Abbondanza, C.; Carlino, M.V.; Giacco, V.; Amato, G.; Carella, C. Decreased serum vascular endothelial growth factor-d levels in metastatic patients with differentiated thyroid carcinoma. Clin. Endocrinol. 2012, 76, 142–146. [Google Scholar] [CrossRef]
  94. Hsueh, C.; Lin, J.D.; Wu, I.C.; Chao, T.C.; Yu, J.S.; Liou, M.J.; Yeh, C.J. Vascular endothelial growth factors and angiopoietins in presentations and prognosis of papillary thyroid carcinoma. J. Surg. Oncol. 2011, 103, 395–399. [Google Scholar] [CrossRef]
  95. Hauslage, J.; Cevik, V.; Hemmersbach, R. Pyrocystis noctiluca represents an excellent bioassay for shear forces induced in ground-based microgravity simulators (clinostat and random positioning machine). NPJ Microgravity 2017, 3, 12. [Google Scholar] [CrossRef]
  96. Wuest, S.L.; Stern, P.; Casartelli, E.; Egli, M. Fluid dynamics appearing during simulated microgravity using random positioning machines. PLoS ONE 2017, 12, e0170826. [Google Scholar] [CrossRef]
  97. Pietsch, J.; Kussian, R.; Sickmann, A.; Bauer, J.; Weber, G.; Nissum, M.; Westphal, K.; Egli, M.; Grosse, J.; Schonberger, J.; et al. Application of free-flow ief to identify protein candidates changing under microgravity conditions. Proteomics 2010, 10, 904–913. [Google Scholar] [CrossRef] [PubMed]
  98. Zhao, C.; Denison, C.; Huibregtse, J.M.; Gygi, S.; Krug, R.M. Human isg15 conjugation targets both ifn-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. USA 2005, 102, 10200–10205. [Google Scholar] [CrossRef] [PubMed]
  99. Morales, D.J.; Lenschow, D.J. The antiviral activities of isg15. J. Mol. Biol. 2013, 425, 4995–5008. [Google Scholar] [CrossRef] [PubMed]
  100. Yao, X.; Guo, S.; Wu, W.; Wang, J.; Wu, S.; He, S.; Wan, Y.; Nandakumar, K.S.; Chen, X.; Sun, N.; et al. Q63, a novel denv2 rdrp non-nucleoside inhibitor, inhibited denv2 replication and infection. J. Pharmacol. Sci. 2018, 138, 247–256. [Google Scholar] [CrossRef]
  101. Bektas, N.; Noetzel, E.; Veeck, J.; Press, M.F.; Kristiansen, G.; Naami, A.; Hartmann, A.; Dimmler, A.; Beckmann, M.W.; Knüchel, R.; et al. The ubiquitin-like molecule interferon-stimulated gene 15 (isg15) is a potential prognostic marker in human breast cancer. Breast Cancer Res. 2008, 10, R58. [Google Scholar] [CrossRef]
  102. Hanke, J.H.; Gardner, J.P.; Dow, R.L.; Changelian, P.S.; Brissette, W.H.; Weringer, E.J.; Pollok, B.A.; Connelly, P.A. Discovery of a novel, potent and src family-selective tyrosine kinase inhibitor. Study of lck- and fynt-dependent t cell activation. J. Biol. Chem. 1996, 271, 695–701. [Google Scholar] [CrossRef]
  103. Sharma, S.; Singh, M.; Sharma, P.L. Ameliorative effect of daidzein: A caveolin-1 inhibitor in vascular endothelium dysfunction induced by ovariectomy. Indian J. Exp. Biol. 2012, 50, 28–34. [Google Scholar]
  104. Liu, M.; Hummer, B.T.; Li, X.; Hassel, B.A. Camptothecin induces the ubiquitin-like protein, isg15 and enhances isg15 conjugation in response to interferon. J. Interferon Cytokine Res. 2004, 24, 647–654. [Google Scholar] [CrossRef]
  105. Zhang, W.; Sun, J.; Luo, J. High expression of rab-like 3 (rabl3) is associated with poor survival of patients with non-small cell lung cancer via repression of mapk8/9/10-mediated autophagy. Med. Sci. Monit. 2016, 22, 1582–1588. [Google Scholar] [CrossRef]
  106. Baeck, C.; Wehr, A.; Karlmark, K.R.; Heymann, F.; Vucur, M.; Gassler, N.; Huss, S.; Klussmann, S.; Eulberg, D.; Luedde, T.; et al. Pharmacological inhibition of the chemokine ccl2 (mcp-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 2012, 61, 416–426. [Google Scholar] [CrossRef]
  107. Dai, Y.; Rahmani, M.; Dent, P.; Grant, S. Blockade of histone deacetylase inhibitor-induced rela/p65 acetylation and nf-kappab activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, xiap downregulation and c-jun n-terminal kinase 1 activation. Mol. Cell. Biol. 2005, 25, 5429–5444. [Google Scholar] [CrossRef]
  108. Zhang, J.; He, D.H.; Zajac-Kaye, M.; Hochwald, S.N. A small molecule fak kinase inhibitor, gsk2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells. Cell Cycle 2014, 13, 3143–3149. [Google Scholar] [CrossRef]
  109. Xu, L.; Wang, W.; Meng, T.; Ma, L.P.; Tong, L.J.; Shen, J.K.; Wang, Y.Q.; Miao, Z.H. New microtubulin inhibitor mt189 suppresses angiogenesis via the jnk-vegf/vegfr2 signaling axis. Cancer Lett. 2018, 416, 57–65. [Google Scholar] [CrossRef]
  110. Wu, B.; Li, J.; Huang, D.; Wang, W.; Chen, Y.; Liao, Y.; Tang, X.; Xie, H.; Tang, F. Baicalein mediates inhibition of migration and invasiveness of skin carcinoma through ezrin in a431 cells. BMC Cancer 2011, 11, 527. [Google Scholar] [CrossRef]
  111. Kreutz, D.; Sinthuvanich, C.; Bileck, A.; Janker, L.; Muqaku, B.; Slany, A.; Gerner, C. Curcumin exerts its antitumor effects in a context dependent fashion. J. Proteom. 2018, 182, 65–72. [Google Scholar] [CrossRef] [PubMed]
  112. Persson, A.; Lindberg, O.R.; Kuhn, H.G. Radixin inhibition decreases adult neural progenitor cell migration and proliferation in vitro and in vivo. Front. Cell Neurosci. 2013, 7, 161. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  113. Placencio, V.R.; Ichimura, A.; Miyata, T.; DeClerck, Y.A. Small molecule inhibitors of plasminogen activator inhibitor-1 elicit anti-tumorigenic and anti-angiogenic activity. PLoS ONE 2015, 10, e0133786. [Google Scholar] [CrossRef] [PubMed]
  114. Kim, H.J.; Kang, G.J.; Kim, E.J.; Park, M.K.; Byun, H.J.; Nam, S.; Lee, H.; Lee, C.H. Novel effects of sphingosylphosphorylcholine on invasion of breast cancer: Involvement of matrix metalloproteinase-3 secretion leading to wnt activation. Biochim. Biophys. Acta 2016, 1862, 1533–1543. [Google Scholar] [CrossRef]
  115. O’Shea, L.K.; Abdulkhalek, S.; Allison, S.; Neufeld, R.J.; Szewczuk, M.R. Therapeutic targeting of neu1 sialidase with oseltamivir phosphate (tamiflu(r)) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance. Onco Targets Ther. 2014, 7, 117–134. [Google Scholar] [CrossRef]
Ijms 20 02553 g001 550
Figure 1. Timeline: research on thyroid cancer in microgravity. White squares: studies in simulated µg; yellow squares: studies in real µg. PFC: parabolic flight campaign, TCC: thyroid cancer cells.
Figure 1. Timeline: research on thyroid cancer in microgravity. White squares: studies in simulated µg; yellow squares: studies in real µg. PFC: parabolic flight campaign, TCC: thyroid cancer cells.
Ijms 20 02553 g001
Ijms 20 02553 g002 550
Figure 2. (A) Currently available and future (*) platforms for research in real µg. The highlighted boxes indicate altitude and duration ranges of the experiments; (B) Different ground-based facilities to simulate µg on Earth. Arrows indicate gravitational forces (Earth gravity) or movements to annulling gravity (“simulated µg”). Parts of the figure were drawn by using pictures from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).
Figure 2. (A) Currently available and future (*) platforms for research in real µg. The highlighted boxes indicate altitude and duration ranges of the experiments; (B) Different ground-based facilities to simulate µg on Earth. Arrows indicate gravitational forces (Earth gravity) or movements to annulling gravity (“simulated µg”). Parts of the figure were drawn by using pictures from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).
Ijms 20 02553 g002
Ijms 20 02553 g003 550
Figure 3. Overview: Current research on thyroid cancer using (simulated) microgravity. Parts of the figure were drawn by using pictures from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).
Figure 3. Overview: Current research on thyroid cancer using (simulated) microgravity. Parts of the figure were drawn by using pictures from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).
Ijms 20 02553 g003
Ijms 20 02553 g004 550
Figure 4. Simulated microgravity affects morphology and growth of thyroid cancer cells: (A) Multicellular spheroid (MCS) of UCLA RO-82W-1 cells, observed after three days on a random positioning machine (RPM). Yellow arrows indicate proliferating areas; (B,C) Fluorescence staining of F-actin (red) in UCLA RO-82W-1 cells that were grown for three days in normal gravity (B) or on an RPM (C). Small MCS were visible with increased F-actin deposits at the outer membranes of the MCS surface (green arrows); (D,E) Immunofluorescence of vinculin (green) in UCLA RO-82W-1 cells. DAPI-stained nuclei are shown in blue. Scale bars: 50 µm.
Figure 4. Simulated microgravity affects morphology and growth of thyroid cancer cells: (A) Multicellular spheroid (MCS) of UCLA RO-82W-1 cells, observed after three days on a random positioning machine (RPM). Yellow arrows indicate proliferating areas; (B,C) Fluorescence staining of F-actin (red) in UCLA RO-82W-1 cells that were grown for three days in normal gravity (B) or on an RPM (C). Small MCS were visible with increased F-actin deposits at the outer membranes of the MCS surface (green arrows); (D,E) Immunofluorescence of vinculin (green) in UCLA RO-82W-1 cells. DAPI-stained nuclei are shown in blue. Scale bars: 50 µm.
Ijms 20 02553 g004
Ijms 20 02553 g005 550
Figure 5. Schematic of the analogy between a multicellular spheroid (left) and a tumour (right) to illustrate the pathophysiological inside-out situation described by Kunz-Schughart [62]. Cap: capillary. Parts of the figure were drawn by using pictures from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).
Figure 5. Schematic of the analogy between a multicellular spheroid (left) and a tumour (right) to illustrate the pathophysiological inside-out situation described by Kunz-Schughart [62]. Cap: capillary. Parts of the figure were drawn by using pictures from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).
Ijms 20 02553 g005
Ijms 20 02553 g006 550
Figure 6. Semantic analysis of factors involved in spheroid formation: (A) Protein-protein regulation of follicular thyroid cancer cells exposed to µg; (B) Direct protein interactions; (C) Gene interaction of various differentially regulated genes of thyroid cancer cells exposed to µg conditions. Connecting lines indicate binding, arrows show directed interaction; green lines with ‘+’ signs point to an enhancing effect, red lines with perpendicular bars indicate inhibition. Networks were built up using Pathway Studio v.11 (Elsevier, Amsterdam, The Netherlands).
Figure 6. Semantic analysis of factors involved in spheroid formation: (A) Protein-protein regulation of follicular thyroid cancer cells exposed to µg; (B) Direct protein interactions; (C) Gene interaction of various differentially regulated genes of thyroid cancer cells exposed to µg conditions. Connecting lines indicate binding, arrows show directed interaction; green lines with ‘+’ signs point to an enhancing effect, red lines with perpendicular bars indicate inhibition. Networks were built up using Pathway Studio v.11 (Elsevier, Amsterdam, The Netherlands).
Ijms 20 02553 g006
Ijms 20 02553 g007 550
Figure 7. Comparison of different cell culture models for thyroid cancer research. s-µg: simulated microgravity. Parts of the figure were drawn by using pictures from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).
Figure 7. Comparison of different cell culture models for thyroid cancer research. s-µg: simulated microgravity. Parts of the figure were drawn by using pictures from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).
Ijms 20 02553 g007
Ijms 20 02553 g008 550
Figure 8. From metastasis-like cell detachment to lower aggressiveness: the transformation of thyroid cancer cells during their exposure to microgravity. The green lines show F-actin filaments. ↓ down-regulation/decrease, ↑ up-regulation/increase.
Figure 8. From metastasis-like cell detachment to lower aggressiveness: the transformation of thyroid cancer cells during their exposure to microgravity. The green lines show F-actin filaments. ↓ down-regulation/decrease, ↑ up-regulation/increase.
Ijms 20 02553 g008
Table
Table 1. Selected articles addressing the mechanisms of spheroid formation of thyroid cancer cells exposed to real or simulated µg.
Table 1. Selected articles addressing the mechanisms of spheroid formation of thyroid cancer cells exposed to real or simulated µg.
Cell LineConditionFindingsRef.
FTC-133Space ISS (5d) preincubation (12d)Factors involved in inhibition of 3D growth: caveolin-1, VCAM-1 and activated protein kinase Cα recruited in caveolae[52]
FTC-133Space ISS (5d) preincubation (12d)Proteins involved in the inhibition of 3D growth: extracellular matrix proteins, phosphorylated profilin 1[53]
FTC-133Space (10d)
Shenzhou 8 		IL6, CXCL8, IL15, SPP1, VEGFA, VEGFD, FGF17, MMP2, MMP3, TIMP1, PRKAA and PRKCA[48]
FTC-133Space (10d)
Shenzhou 8 		CTGF and EGF[63]
FTC-133RPM 3d, (2d) preincubation (5d) preincubationVinculin, paxillin, focal adhesion kinase 1 and adenine diphosphate (ADP)-ribosylation factor 6[45]
FTC-133, Nthy-ori 3-1RPM (14d)VEGF, FLT-1. FLK-1, CD44, Copine 1, TGM2, IL-6, IL-8, IL-17, OPN, neutrophil gelatinase-associated lipocalin (NGAL, LCN2)[6]
ML-1, RO82-W-1RPM (3d), FRC (7d)ML-1 cells: elevated release of IL-6 and monocyte chemoattractant protein (MCP-1)[64]
Table
Table 2. Genes involved in spheroid formation.
Table 2. Genes involved in spheroid formation.
Pathway/FunctionGenes
Cell adhesionVCAM1, CD44, CDH1
Angiogenesis VEGFD, VEGFA, FLK1
ApoptosisTGFB1
CaveolaeCAV1
Extracellular matrixSPP1, MMP2, MMP3, TIMP1, FN1, COL1A1
InflammationIL6, CXCL8, IL17
NFκB signallingNFKB1
Protein kinasesPRKAA, PRKCA
CytoskeletonACTB, TUBB, FN1
Table
Table 3. Comparison between exposure to µg and metastasis.
Table 3. Comparison between exposure to µg and metastasis.
Microgravity (Detachment)Metastases (Detachment)
Physical TriggerLapse of gravity (tensegrity, mechanical stress)Pressure from growing tumour
CytoskeletonFormation of filopodia and lamellipodia [49]Formation of filopodia and lamellipodia [85]
PFN↑ [6], phosphorylated profilin-1 prevented MCS formation [43]Profilin 1↓ [86]
Cell AdhesionBlockage of E-cadherin leads to enhanced spheroid formation of MCF-7 breast cancer cells [65]E-cadherin↓ [87]
ECMMMP9↑ [43]; OPN↑ [61]MMP9↑ [88]; OPN↑ [89]
CytokinesIL-6↑, IL-8↑ [6]IL-6↑ [87]; IL-8 enhances metastatic potential [90]
Growth FactorsVEGF-A↑ [48]VEGF↑ facilitates metastasis through the VEGF-VEGFR1 signalling pathway [91]
OthersCD44↑ [61]CD44↑ [92]
↓ down-regulation; ↑ up-regulation; AD: adherent cells; MCS: multicellular spheroids.
Table
Table 4. Potential drugs targeting the proteins that were found to be influenced by µg.
Table 4. Potential drugs targeting the proteins that were found to be influenced by µg.
DrugTargetRef.
PP2 (4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine)Proto-oncogene tyrosine-protein kinase Src[102]
DaidzeinCaveolin-1[103]
CamptothecinUbiquitin-like protein ISG15[104]
SP600125Mitogen-activated protein kinase 8[105]
mNOX-E36C-C motif chemokine 2[106]
Dexamethasone, BAY 11-7082NFκB p65[107]
GSK2256098, MPAPFocal adhesion kinase 1[108]
MT189Paxillin[109]
BaicaleinEzrin[110]
CurcuminHMOX-1[111]
DX52-1Radixin[112]
TM5441Plasminogen activator inhibitor 1[113]
UK370106Stromelysin, (MMP3)[114]
OseltamivirSialidase[115]

Share and Cite

MDPI and ACS Style

Krüger, M.; Melnik, D.; Kopp, S.; Buken, C.; Sahana, J.; Bauer, J.; Wehland, M.; Hemmersbach, R.; Corydon, T.J.; Infanger, M.; et al. Fighting Thyroid Cancer with Microgravity Research. Int. J. Mol. Sci. 2019, 20, 2553. https://doi.org/10.3390/ijms20102553

AMA Style

Krüger M, Melnik D, Kopp S, Buken C, Sahana J, Bauer J, Wehland M, Hemmersbach R, Corydon TJ, Infanger M, et al. Fighting Thyroid Cancer with Microgravity Research. International Journal of Molecular Sciences. 2019; 20(10):2553. https://doi.org/10.3390/ijms20102553

Chicago/Turabian Style

Krüger, Marcus, Daniela Melnik, Sascha Kopp, Christoph Buken, Jayashree Sahana, Johann Bauer, Markus Wehland, Ruth Hemmersbach, Thomas J. Corydon, Manfred Infanger, and et al. 2019. "Fighting Thyroid Cancer with Microgravity Research" International Journal of Molecular Sciences 20, no. 10: 2553. https://doi.org/10.3390/ijms20102553

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop